1. Comparison of IVIg 5% Versus 10% in hematological patients with a secondary immunodeficiency disorder. Issue 1 (2nd January 2021) Authors: Van Ham, Jonas; Janssens, Ann; Raddoux, Jolien; Raets, Els; Delforge, Michel Journal: Acta clinica belgica Issue: Volume 76:Issue 1(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial. Issue 2 (1st February 2016) Authors: Delforge, Michel; Devos, Timothy; Rowe, Jacob; Español, Ignacio; Durrant, Simon T.; Raddoux, Jolien; Boogaerts, Marc; Gramatzki, Martin; Gunther, Andreas Journal: Leukemia & lymphoma Issue: Volume 57:Issue 2(2016:Feb.) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗